These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9668284)

  • 1. Rapsyn antibodies in myasthenia gravis.
    Agius MA; Zhu S; Kirvan CA; Schafer AL; Lin MY; Fairclough RH; Oger JJ; Aziz T; Aarli JA
    Ann N Y Acad Sci; 1998 May; 841():516-21. PubMed ID: 9668284
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibodies to AChR, synapse-organizing proteins, titin, and other muscle proteins in Morvan's fibrillary chorea.
    Agius MA; Zhu S; Lee EK; Aarli JA; Kirvan C; Fairclough RH; Maselli R
    Ann N Y Acad Sci; 1998 May; 841():522-4. PubMed ID: 9668285
    [No Abstract]   [Full Text] [Related]  

  • 3. Agrin-induced aggregation of acetylcholine receptors in muscles of rats with experimental autoimmune myasthenia gravis.
    Rimer M
    Ann N Y Acad Sci; 1998 May; 841():546-9. PubMed ID: 9668292
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunisation with Torpedo acetylcholine receptor.
    Elfman L
    Prog Neurobiol; 1984; 23(1-2):39-62. PubMed ID: 6097937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antirapsyn antibodies occur commonly in patients with lupus.
    Agius MA; Zhu S; Aarli JA
    Ann N Y Acad Sci; 1998 May; 841():525-6. PubMed ID: 9668286
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimental rabbit model of myasthenia gravis produced with acetylcholine receptor of nicotinic type from the "generating organ" of electric ray (author's transl)].
    Tu LH
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1981 Feb; 14(1):16-8. PubMed ID: 7307781
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-acetylcholine receptor antibodies in myasthenia gravis: binding to membrane-bound Torpedo AChR.
    Koethe SM; DuPont BL; Calvo AM; Otterson G; McQuillen MP
    Ann N Y Acad Sci; 1987; 505():557-65. PubMed ID: 3479936
    [No Abstract]   [Full Text] [Related]  

  • 8. Major pathogenic effects of anti-MuSK antibodies in myasthenia gravis.
    Boneva N; Frenkian-Cuvelier M; Bidault J; Brenner T; Berrih-Aknin S
    J Neuroimmunol; 2006 Aug; 177(1-2):119-31. PubMed ID: 16857268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiacetylcholine receptor antibodies and myasthenia gravis.
    Fulpius BW
    Int Rev Neurobiol; 1983; 24():1-14. PubMed ID: 6197385
    [No Abstract]   [Full Text] [Related]  

  • 10. Switch to double positive late onset MuSK myasthenia gravis following thymomectomy in paraneoplastic AChR antibody positive myasthenia gravis.
    Jordan B; Schilling S; Zierz S
    J Neurol; 2016 Jan; 263(1):174-6. PubMed ID: 26645394
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental myasthenia gravis: a model of receptor disease.
    Takamori M; Kasai M
    Int J Neurol; 1980; 14(1):47-60. PubMed ID: 6293991
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antibodies to acetylcholine receptor. Diagnosis and therapeutic interest in myasthenia gravis (author's transl)].
    de Crousaz G
    Ann Chir; 1980 Mar; 34(3):188-92. PubMed ID: 7369693
    [No Abstract]   [Full Text] [Related]  

  • 13. Production and assay of antibodies to acetylcholine receptors.
    Lindstrom J; Einarson B; Tzartos S
    Methods Enzymol; 1981; 74 Pt C():432-60. PubMed ID: 7321891
    [No Abstract]   [Full Text] [Related]  

  • 14. Susceptibility of HLA DR3 transgenic mice to experimental autoimmune myasthenia gravis.
    Raju R; Zhan WZ; Karachunski P; Sieck GC; Conti-Fine BM; David CS
    Ann N Y Acad Sci; 1998 May; 841():360-4. PubMed ID: 9668259
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of experimental autoimmune myasthenia gravis by manipulation of the immune network with a complementary peptide for the acetylcholine receptor.
    Araga S; LeBoeuf RD; Blalock JE
    Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8747-51. PubMed ID: 8378359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of anti-idiotopic antibody on the course of experimental autoimmune myasthenia gravis.
    Agius MA; Yuen E
    Ann N Y Acad Sci; 1998 May; 841():584-6. PubMed ID: 9668301
    [No Abstract]   [Full Text] [Related]  

  • 17. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma.
    Mygland A; Tysnes OB; Matre R; Volpe P; Aarli JA; Gilhus NE
    Ann Neurol; 1992 Oct; 32(4):589-91. PubMed ID: 1333745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG subclass distribution of ryanodine receptor autoantibodies in patients with myasthenia gravis and thymoma.
    Mygland A; Tysnes OB; Aarli JA; Matre R; Gilhus NE
    J Autoimmun; 1993 Aug; 6(4):507-15. PubMed ID: 8216692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental myasthenia gravis is inhibited by receptor-antireceptor complexes.
    Barkas T; Simpson JA
    J Clin Lab Immunol; 1982 Apr; 7(3):223-7. PubMed ID: 7097749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pseudo-internuclear ophthalmoplegia in myasthenia gravis].
    Bogdan I; Crisanda V
    Oftalmologia; 2011; 55(3):70-3. PubMed ID: 22428294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.